Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Landiol for Tachyarrhythmia 1Recommended for Approval
June 10, 2002
- Shionogi: Net Profits Plummet 33% Due to Restructuring
June 10, 2002
- Kyowa Hakko: Drug Sales Up 0.6% to \142.2 Bil.
June 10, 2002
- Korosho to Accelerate Approval of Overseas Anticancer Agents
June 10, 2002
- Chugai: Sales Up 6.7% Due to Good Performance of Mainstays
June 10, 2002
- Kuraya Sanseido: Sales, Profits Sharply Up Due to Cost Cutting
June 10, 2002
- Time Is Running Out for Passage of Healthcare Reform Bills
June 10, 2002
- Dainippon: Sales, Profits Up 3 Years in a Row
June 10, 2002
- Suzuken: Consolidated Sales Up to \955.7 Bil.
June 10, 2002
- Revised Forecasts of Social Security Benefits Released
June 10, 2002
- Takeda: Becomes 1st Japanese Drug House with Sales of Over \1 Trillion
June 10, 2002
- Azwell: Operating Profits Return to Black
June 10, 2002
- Model Curriculum for Pharmacists Drafted by PSJ
June 10, 2002
- Eisai: Overseas Sales Up 53%, Accounting for 42.9% of Total Sales
June 3, 2002
- Taiho Aims at Sales of \140 Bil. in 2004
June 3, 2002
- Daiichi: Record-high Sales, Profits Thanks to Cravit
June 3, 2002
- BUSINESS NEWS IN BRIEF
June 3, 2002
- Taisho: Sales Down 1.1% due to Slump of OTC Drugs
June 3, 2002
- NEW PRODUCTS
June 3, 2002
- Banyu: Nu-lotan Contributes to Good Sales, Profits
June 3, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…